getting pregnant on tirzepatide Does Cause Birth Defects? Evidence and Safety Guidance Tirzepatide & Fertility: Safety Evidence

Current Status of GLP-1 Medications The FDA has officially determined that the shortage of both semaglutide and tirzepatide injection products is now resolved

January 2024 : A patient taking semaglutide presented with gastroparesis which greatly improved when she stopped taking the medication

Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and severe renal or hepatic impairment

Nausea, diarrhea and vomiting were most common, and about one in five patients reported mild dysesthesia